445 Pill - yellow round, 9mm
Pill with imprint 445 is Yellow, Round and has been identified as Donepezil Hydrochloride 10 mg. It is supplied by Caraco Pharmaceutical Laboratories, Ltd.
Donepezil is used in the treatment of Alzheimer's Disease and belongs to the drug class cholinesterase inhibitors. Risk cannot be ruled out during pregnancy. Donepezil 10 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 445
Donepezil Hydrochloride
- Imprint
- 445
- Strength
- 10 mg
- Color
- Yellow
- Size
- 9.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Cholinesterase inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Caraco Pharmaceutical Laboratories, Ltd.
- Inactive Ingredients
-
lactose monohydrate,
microcrystalline cellulose,
corn starch,
hydroxypropyl cellulose,
low substituted hydroxypropyl cellulose,
magnesium silicate,
magnesium stearate,
polyethylene glycol,
hypromelloses,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
62756-0445 (Discontinued) | Sun Pharmaceutical Industries Inc. |
68084-0734 (Discontinued) | Amerisource Health Services |
Related images for "445"
More about donepezil
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (133)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: cholinesterase inhibitors
Patient resources
- Donepezil drug information
- Donepezil skin patch
- Donepezil (Oral) (Advanced Reading)
- Donepezil (Transdermal) (Advanced Reading)
- Donepezil 23 mg Tablets
- Donepezil Orally Disintegrating Tablets
Other brands
Aricept, Aricept ODT, Adlarity
Professional resources
- Donepezil monograph
- Donepezil (FDA)
- Donepezil ER Tablets (FDA)
- Donepezil Orally Disintegrating Tablet (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.